GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Horizon Therapeutics Public Limited Company Stock and on which exchange is it traded?
The symbol for Horizon Therapeutics Public Limited Company is HZNP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Horizon Therapeutics Public Limited Company Stock?
Horizon Therapeutics Public Ltd Co holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Horizon Therapeutics Public Limited Company Stock?
Horizon Therapeutics Public Limited Company Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Horizon Therapeutics Public Limited Company Stock.

What's the current price of Horizon Therapeutics Public Limited Company Stock?
As of the end of day on the 2024-01-04, the price of an Horizon Therapeutics Public Limited Company (HZNP) share was $116.30.

What is the 52-week high and low for Horizon Therapeutics Public Limited Company Stock?
The 52-week high for Horizon Therapeutics Public Limited Company Stock is $116.38 and the 52-week low is $90.61.

What is the market capitalization of Horizon Therapeutics Public Limited Company Stock?
As of the 2024-01-04, the market capitalization of Horizon Therapeutics Public Limited Company is 26.632B.
Click to get the best stock tips daily for free!

About Horizon Therapeutics Public Limited Company

Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-... HZNP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT